Previous Close | 31.60 |
Open | 32.00 |
Bid | 32.40 x 200000 |
Ask | 32.60 x 200000 |
Day's Range | 32.00 - 32.00 |
52 Week Range | 16.20 - 35.20 |
Volume | |
Avg. Volume | 6 |
Market Cap | 469.219M |
Beta (5Y Monthly) | 1.04 |
PE Ratio (TTM) | 36.36 |
EPS (TTM) | 0.88 |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 76.25 |
Key Insights The projected fair value for Surmodics is US$68.80 based on 2 Stage Free Cash Flow to Equity Surmodics is...
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
Shareholders will be ecstatic, with their stake up 24% over the past week following Surmodics, Inc. 's ( NASDAQ:SRDX...